http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28875771

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 1269
issn 1527-6465
issueIdentifier 10
pageRange 1262-1269
publicationName Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
startingPage 1262
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bd9a9804daa4363cb01650b2c04421a6
bibliographicCitation De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial. Liver Transpl. 2009 Oct;15(10):1262–9. doi: 10.1002/lt.21827. PMID: 19790150.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0a9bb3ba4031b0e62aef14d5556c119
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3894-8767
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14d26579d4aa3609e98865a64c1af66d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa3f4d5f3af9bb3601c8f1a46e342d4f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54e0d023b35aa7ab0eaf650160f1f889
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79be4a83d49ffbf321e5a2fc7ea76129
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4536a5584b1a4ec371fc1390317de434
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6713-6170
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e589564a401af7f5c56ee5e0bbe59b6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a58289097395efc2510995f562605439
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1968249d6b7101f882151f1e9a7638d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_259a0f05470a7374d22e10929ed073ca
date 2009-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1002/lt.21827
https://pubmed.ncbi.nlm.nih.gov/19790150
isPartOf https://portal.issn.org/resource/ISSN/1527-6465
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21611
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial
discusses http://id.nlm.nih.gov/mesh/M0587252
http://id.nlm.nih.gov/mesh/M0011171
http://id.nlm.nih.gov/mesh/M000602394
http://id.nlm.nih.gov/mesh/M0029863
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D020123Q000031
http://id.nlm.nih.gov/mesh/D016031Q000379
http://id.nlm.nih.gov/mesh/D008107Q000628
http://id.nlm.nih.gov/mesh/D065095
hasSubjectTerm http://id.nlm.nih.gov/mesh/D020123Q000627
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006085
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006084
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D001706
http://id.nlm.nih.gov/mesh/D000068338
http://id.nlm.nih.gov/mesh/D007166Q000627
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242749350

Total number of triples: 60.